The Latest Medical News

A Summary of The Latest Medical News: **New Study Links Gabapentin Use for Back Pain to Higher Dementia and Cognitive Risk** A large new study has found that people who receive six or more prescriptions of gabapentin to treat lower back pain may face a significantly elevated risk of developing dementia and mild cognitive impairment (MCI)[4][1][5]. **Understanding Gabapentin and Its Uses** Gabapentin is a medication commonly prescribed for nerve pain and is approved by the FDA for the treatment of partial seizures and postherpetic neuralgia. However, it is widely used "off-label" for chronic pain conditions, such as lower back pain, due to its perceived safety compared to opioids[2][1]. **Key Findings: Increased Risk of Dementia and MCI** The study analyzed electronic health records from a national database and included over 26,000 adults with chronic low back pain, tracked over a period of up to 10 years[3][5]. Researchers found that: - Patients who received six or more gabapentin prescriptions had a **29% higher risk of developing dementia** compared to similar chronic pain patients who did not take gabapentin[4][2][1][5]. - The risk of being diagnosed with **mild cognitive impairment (MCI)** was **85% higher** in patients with six or more gabapentin prescriptions[4][2][1]. - The risks were even greater among younger adults aged 35 to 49, with dementia risk more than doubling and MCI risk more than tripling in these age groups[5][1][4]. **Who Is Most at Risk?** While dementia is primarily associated with older adults, the most striking finding was that the risk increase was highest among younger, nonelderly adults taking gabapentin. In adults aged 35–49, the risk for dementia and cognitive decline was significantly higher compared to older groups[5][1][4]. **Study Methods** The research team from Case Western Reserve University and colleagues used data from 68 healthcare organizations across the United States. They excluded patients with prior gabapentin use, dementia, epilepsy, stroke, or cancer to minimize confounding factors. Propensity-score matching helped ensure that groups were balanced in terms of demographics, medical conditions, and use of other pain medications[3][2][5]. **Clinical Implications and Recommendations** Researchers highlight that although their findings show an association between prolonged gabapentin use and cognitive risks, the study does not prove the medication causes dementia or MCI. They recommend physicians regularly perform cognitive assessments on patients taking gabapentin for chronic pain and advise patients to promptly report any issues with memory, confusion, or slowed thinking[1]. **Growing Caution Over Gabapentin's Long-Term Effects** Gabapentin is increasingly considered a safer alternative to opioids, but this study adds to concerns about its neurological safety when used chronically for pain. Clinicians and pharmacists are urged to be aware of these risks, especially when prescribing gabapentin to middle-aged adults[2][4]. **Next Steps and Research Needs** The authors emphasize the need for further studies to clarify whether gabapentin directly causes cognitive decline and to understand the mechanisms involved, especially given the heightened vulnerability among nonelderly populations[1][5][4]. Help with your insurance? https://tally.so/r/n012P9